Research has found that in co-cultures of neutrophils and SW480 cells (colon adenocarcinoma cells), neutralizing TGFβ with monoclonal antibodies inhibits cancer cell migration and enhances cytotoxicity of neutrophils targeting cancer cells (119–121). This evidence concerns the gene TGFB1 and cancer.